{
    "id": 26801,
    "fullName": "DDIT4 positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "DDIT4 positive indicates the presence of the DDIT4 gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 54541,
        "geneSymbol": "DDIT4",
        "terms": [
            "DDIT4",
            "Dig2",
            "REDD-1",
            "REDD1"
        ]
    },
    "variant": "positive",
    "createDate": "07/25/2017",
    "updateDate": "07/29/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 11499,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, treatment with Baicalein resulted in cell growth inhibition, increased DDIT4 expression, and inhibition of the activation of mTORC1 targets in ovarian cancer cells in culture (PMID: 25543165).",
            "molecularProfile": {
                "id": 28101,
                "profileName": "DDIT4 positive"
            },
            "therapy": {
                "id": 4763,
                "therapyName": "Baicalein",
                "synonyms": null
            },
            "indication": {
                "id": 2394,
                "name": "ovarian cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3406,
                    "pubMedId": 25543165,
                    "title": "Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25543165"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 11498,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Baicalein resulted in cell growth inhibition of triple-receptor negative breast cancer cells in culture, and in xenograft models induced apoptotic activity, increased DDIT4 protein expression, and suppressed tumor growth (PMID: 25543165).",
            "molecularProfile": {
                "id": 28101,
                "profileName": "DDIT4 positive"
            },
            "therapy": {
                "id": 4763,
                "therapyName": "Baicalein",
                "synonyms": null
            },
            "indication": {
                "id": 60081,
                "name": "triple-receptor negative breast cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3406,
                    "pubMedId": 25543165,
                    "title": "Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25543165"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 28101,
            "profileName": "DDIT4 positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}